module 6. m&emodule 6. monitoring and evaluation (m&e) session 1. introduction monitoring...

23
PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS Module 6. Monitoring and Evaluation (M&E) Session 1. Introduction

Upload: others

Post on 11-Jan-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)

Session 1. Introduction

Page 2: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Session 1 Objectives

• To introduce Monitoring and Evaluation (M&E)- what is M&E and why is it important.

• To describe the NTD M&E Results Frameworks.

• To identify key indicators used to measure NTDPs.– To identify NTDP coverage goals

2

Page 3: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Monitoring and Evaluation

• What is ‘monitoring’?

• What is ‘evaluation’?

3

Page 4: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Monitoring

• The routine process of data collection (monthly, quarterly, annually) intended to measure whether the program is doing what is set out to do.

Evaluation

• The systematic investigation of whether a program is effective: whether the activities implemented are having the desired effect.

• Evaluations are carried out periodically (mid project/end of project).

4

Page 5: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

The NTDP Road Map

1. Where are you going?

2. How will you get there?

3. What will tell you that you are going in the right direction?

4. What will tell you that you have arrived?

5

ALL M&E PLANS MUST START WITH UNDERSTANDING THE PROGRAMME – IT’S

GOALS AND ACTIVITIES.

Page 6: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Results Framework

• The Results Framework is your NTDP roadmap.

• It links the intervention (programme activities) to programme goals and objectives. – Where you are going and how you will get there

• Based on this you chose measures that will tell you if you have achieved the programme goals and objectives.– Measures of whether you are going in the right direction and have you arrived

6

Page 7: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

FIRST – DESCRIBE THE PROGRAMME ACTIVITIES, OBJECTIVES AND GOALS

7

Page 8: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

INPUTS

What we invest

ACTIVITIES

What we do

OUTCOMES

The resultsShort term --------------------Long term

IMPACTOUTPUTS

8

Page 9: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Example: Public Health Interventions for Control of Type 2 Diabetes

9

INPUTS

Church groupsHealth workersTrainersBudget Venue

ACTIVITIES

Community outreach, exercise classes, and cooking groups

OutputsKnowledge and awareness for diabetes dietary risk factors, skills for healthy cooking

RESULTS

OutcomesHealthy eating and exercise habits formed

ImpactReduced incidence of diabetes

Page 10: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Group Exercise: 15 Minutes

What are the following in an NTD programme?

• Inputs

• Activities

• Short/Medium term results (Output/Outcome)

• Long term results (Impact)– Write these up on flip chart pages and stick to the wall

10

Page 11: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Example: AFRO NTD Results Framework

11

AFRO M&E Framework: Logic Model

Page 12: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

SECOND – DECIDE HOW YOU WILL MEASURE YOUR PROGRAMME

12

Page 13: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Indicators

• Indicators are are what we use to measure our programme – to tell us if we are going in the right direction and whether we have arrived.

13

What indicators do we use to measureNTD programmes?

Think of indicators that measure:1. If you got your inputs

2. If you did the activities as planned?3. If you are seeing the expected short term results?

4. If you are seeing the expected impact?

Page 14: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

How Do We Collect the Data to Measure the Indicators?• Different types of data:

– Quantitative

– Qualitative

– Secondary

• Programme routine records– Treatment reporting forms

– Drug reporting forms

– etc

• Interviews with district/community level

• Survey protocols – diagnostic tools, sampling strategies

14

Page 15: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Three Main Categories of Indicators for Monitoring Preventive Chemotherapy

15

Page 16: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Key M&E IndicatorsProcess/performance

indicators

Number of SAEs

Survey Coverage

Reported Treatment Coverage

Data quality indicators

Drug efficacy

Managing MDAs Su

rve

illan

ce

Se

tting

Up

PlanningDrug

management

Data management

system

PC safety

Social mobilization,

advocacy, IEC materials

Training & supervision

MDA implementation

Implementing a Programme

16

Social mobilization,

advocacy, IEC materials

Page 17: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

WE MEASURE AND COMPARE TO TARGETS

TREATMENT COVERAGE IS A KEY INDICATOR OF SUCCESS DURING MDA IMPLEMENTATION PHASE

17

Page 18: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

NTD National coverage goals

LF 65%

Oncho 65% (80%)*

STH and Schisto for SAC 75%

Trachoma 80%

What Are the Target Coverage Goals for NTDP?

18

* 80% target set by researchers (in peer reviewed journals), and being updated for Oncho elimination targeting 2020.

Page 19: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

INFECTION/DISEASE PREVALENCE IS THE KEY INDICATOR TO MEASURE WHETHER WE HAVE REACHED OUR GOAL

19

Page 20: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Key M&E Indicators

Infection prevalence

Disease Prevalence

Surveillance

Se

tting

Up

Ma

na

gin

g M

DA

s

Deciding to scale down

or stop MDA

Surveillance

Other non-PC activities

Ending the Programme

20

Page 21: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Disease GOALS

LF Global Elimination by 2020

Blinding TrachomaGlobal Elimination by 2020

Oncho Regional and country elimination where possible, otherwise control

Schisto Control to low burden

STHControl to low burden

What Are the Disease Specific Goals?

21

Page 22: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

What do you think are the

key messages from this session?

22

Page 23: Module 6. M&EModule 6. Monitoring and Evaluation (M&E) Session 1. Introduction Monitoring • The routine process of data collection (monthly, quarterly, annually) intended to measure

PROGRAMME MANAGERS’ TRAINING COURSE FOR NTDS TARGETED FOR CONTROL OR ELIMINATION BY PREVENTIVE CHEMOTHERAPY INTERVENTIONS

Module 6. Monitoring and Evaluation (M&E)Session 1. Introduction

Key Messages

• Important to have a national M&E plan for NTDP.

• M&E plan should contain the results framework related to your national NTD Plan of Action.

• Indicators are used to measure progress against the results framework.– Coverage is the core performance indicator common to all NTDPs

– Infection/disease prevalence/disease-specific indicators measure program impact

23